Atai Beckley-Lilly merger clears US antitrust waiting period
ATAI•Other regulatory updates
UK competition officials indicated on Aug. 21, 2026 they had no further questions on the transaction.
Australia’s competition regulator cleared the deal subject to a 14-day waiting period set to end at 10:00 a.m. ET on Sept. 10, 2026.
Merger clears U.S. antitrust waiting period
Eli Lilly plans to acquire Atai Beckley via a merger, leaving Atai Beckley as a wholly owned Lilly subsidiary.
The U.S. antitrust waiting period tied to the deal expired at 11:59 p.m. ET on Aug. 28, 2026.
